| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Use Factoring to Grow Your Business, Don't Wait Until You Are Struggling |
|
E-Folder - Use Factoring to Grow Your Business, Don't Wait Until You Are Struggling
Have you ever refused a job or an order because your business didn’t have enough
capital to purchase the supplies or hire the extra staff? You build a good reputation,
hav According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e good workers and then when you finally get a nice big contract, you have to
turn it down because all your money is tied up in accounts receivables. You know
the bills wi ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ll be paid, but they aren’t due quite yet so you are the one who suffers
because of cash flow problems. If you have customers who are established, are good credit risks and lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. almost always
pay on time, you can sell those invoices to an investor (a factor). The factor will give
you an advance of 70% to 90% when the invoice is issued and will wa here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe it for the bill to
be paid. Then you will get the rest of the money minus a small fee of 1% to 5%. The
advance and fee depend on monthly volume, size of invoice, credit, t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ime it takes to
be paid and other things. Some business people who call me are under the impression that the advance of 70% to 90% is all they get. They are thrilled when ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc they discover they get the rest
when the bill is paid except for the small fee. So they actually get 95% to 99% of
their invoice. Factoring isn’t a loan, it isn’t a cred easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi it line, you don’t have debts to pay back, you
don’t tie up any assets other than the invoices, it only takes a few days to get
approved and you keep complete control of y nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically our company. Almost any business can use factoring, so long as they have invoices that are issued to another business. Even a business in Chapter 11 can have their receivab and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ les
factored. Different factors have different requirements, minimums, maximums, fees,
rates and applications to fill out. Some have a small application fee, many do not. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi There are factors who work with any industry except construction and medical. There are others who specialize in construction contractors and others in medical receivable ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s. These two have specific rules and regulations and risks and you
definitely want a factor who specializes in them. A good broker will be working with several factors and dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod should be able to find the
best factoring company for you. The broker will work for you, will get your
questions answered and will be able to go to a second factor if the cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin first one doesn’t
fit your needs. The broker gets paid directly by the factor and your rates and fees
are not affected. Quite often business people think of using a facto tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen r as a last resort when their
business is struggling and they are trying to survive. In reality, businesses should
consider a factor when they are starting out, so they ca t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel n keep their business
growing. They should definitely use a factor when they are feeling confident about
their business and are ready for growth. The businesses you do th ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e work for simply have a different address to send the
payment to; they still do the work for you, get the invoice from you and have the
same payment terms as they always y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products do. Just think how your business could grow if you were paid most of each invoice when you issue it: you could get discounts when you buy your supplies if you pay cash, y . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ou could do more marketing, hire more staff, buy more equipment, increase your
own credit rating. Instead of focusing on collecting the payments you could
concentrate on g elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip oing after more contracts. Then next time a customer calls you with a big contract, you just have to get the papers signed and get on with the work. Sounds good, doesn’t it tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Top 3 Reasons For Writing Business Plans How You and Your Business Can Benefit from an Answering Service
|